ArticleHemaSphere2026

Prognostic value of measurable residual disease in high-risk MDS after intensive chemotherapy in HOVON-SAKK studies.

Coen R Veenstra et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.